{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:16:45Z","timestamp":1726719405127},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00063-024-01167-3","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T16:02:16Z","timestamp":1723564936000},"page":"458-464","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blutungen bei Lebererkrankungen","Bleeding in liver diseases"],"prefix":"10.1007","volume":"119","author":[{"given":"Andreas","family":"Drolz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"1","key":"1167_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13054-024-04938-8","volume":"28","author":"SR Goble","year":"2024","unstructured":"Goble\u00a0SR et\u00a0al (2024) Critical care outcomes in decompensated cirrhosis: a\u00a0United States national inpatient sample cross-sectional study. Crit Care 28(1):150","journal-title":"Crit Care"},{"key":"1167_CR2","doi-asserted-by":"crossref","unstructured":"Karvellas CJ, Gustot T, Fernandez J (2023) Management of the acute on chronic liver failure in the intensive care unit. Liver Int","DOI":"10.1111\/liv.15659"},{"issue":"4","key":"1167_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis\u00a0R et\u00a0al (2022) Baveno VII \u2013 Renewing consensus in portal hypertension. J\u00a0Hepatol 76(4):959\u2013974","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"1167_CR4","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","volume":"62","author":"V Arroyo","year":"2015","unstructured":"Arroyo\u00a0V et\u00a0al (2015) Acute-on-chronic liver failure: A\u00a0new syndrome that will re-classify cirrhosis. J\u00a0Hepatol 62(1 Suppl):S131\u2013S143","journal-title":"J Hepatol"},{"issue":"7","key":"1167_CR5","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau\u00a0R et\u00a0al (2013) Acute-on-chronic liver failure is a\u00a0distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144(7):1426\u20131437 e\u20119","journal-title":"Gastroenterology"},{"issue":"1","key":"1167_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao\u00a0G et\u00a0al (2017) Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 65(1):310\u2013335","journal-title":"Hepatology"},{"issue":"4","key":"1167_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cld.2019.07.002","volume":"23","author":"DC Rockey","year":"2019","unstructured":"Rockey\u00a0DC (2019) An Update: Portal Hypertensive Gastropathy and Colopathy. Clin Liver Dis 23(4):643\u2013658","journal-title":"Clin Liver Dis"},{"issue":"3","key":"1167_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1089-3261(05)70190-2","volume":"5","author":"SK Sarin","year":"2001","unstructured":"Sarin\u00a0SK, Agarwal\u00a0SR (2001) Gastric varices and portal hypertensive gastropathy. Clin Liver Dis 5(3):727\u2013767","journal-title":"Clin Liver Dis"},{"issue":"7","key":"1167_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1365-2036.2006.02842.x","volume":"23","author":"E Cholongitas","year":"2006","unstructured":"Cholongitas\u00a0E et\u00a0al (2006) Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 23(7):883\u2013893","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1167_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/hep.28628","volume":"64","author":"A Drolz","year":"2016","unstructured":"Drolz\u00a0A et\u00a0al (2016) Coagulation parameters and major bleeding in critically ill patients with cirrhosis. Hepatology 64(2):556\u2013568","journal-title":"Hepatology"},{"issue":"5","key":"1167_CR11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/hep.29694","volume":"67","author":"RT Stravitz","year":"2018","unstructured":"Stravitz\u00a0RT et\u00a0al (2018) Bleeding complications in acute liver failure. Hepatology 67(5):1931\u20131942","journal-title":"Hepatology"},{"issue":"1","key":"1167_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1378\/chest.09-3081","volume":"139","author":"H Decousus","year":"2011","unstructured":"Decousus\u00a0H et\u00a0al (2011) Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 139(1):69\u201379","journal-title":"Chest"},{"issue":"2","key":"1167_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1378\/chest.14-2842","volume":"149","author":"DC Hostler","year":"2016","unstructured":"Hostler\u00a0DC et\u00a0al (2016) Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score. Chest 149(2):372\u2013379","journal-title":"Chest"},{"issue":"5","key":"1167_CR14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00134-015-3725-1","volume":"41","author":"M Krag","year":"2015","unstructured":"Krag\u00a0M et\u00a0al (2015) Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 41(5):833\u2013845","journal-title":"Intensive Care Med"},{"issue":"5","key":"1167_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/hep.29056","volume":"65","author":"C Villanueva","year":"2017","unstructured":"Villanueva\u00a0C et\u00a0al (2017) A\u00a0randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis. Hepatology 65(5):1693\u20131707","journal-title":"Hepatology"},{"issue":"3","key":"1167_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/hep.1840050313","volume":"5","author":"G Garcia-Tsao","year":"1985","unstructured":"Garcia-Tsao\u00a0G et\u00a0al (1985) Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5(3):419\u2013424","journal-title":"Hepatology"},{"issue":"12","key":"1167_CR17","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1007\/s10620-006-9310-2","volume":"51","author":"M Wadhawan","year":"2006","unstructured":"Wadhawan\u00a0M et\u00a0al (2006) Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child\u2019s status. Dig Dis Sci 51(12):2264\u20132269","journal-title":"Dig Dis Sci"},{"key":"1167_CR18","unstructured":"Paternostro R et\u00a0al (2024) Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD. J\u00a0Hepatol"},{"issue":"3","key":"1167_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ajg.2011.456","volume":"107","author":"V Hernandez-Gea","year":"2012","unstructured":"Hernandez-Gea\u00a0V et\u00a0al (2012) Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers. Am J Gastroenterol 107(3):418\u2013427","journal-title":"Am J Gastroenterol"},{"key":"1167_CR20","doi-asserted-by":"publisher","first-page":"1060073","DOI":"10.3389\/fmed.2023.1060073","volume":"10","author":"RK Jagdish","year":"2023","unstructured":"Jagdish\u00a0RK et\u00a0al (2023) Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure. Front Med 10:1060073","journal-title":"Front Med"},{"issue":"4","key":"1167_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/hep.21303","volume":"44","author":"SH Caldwell","year":"2006","unstructured":"Caldwell\u00a0SH et\u00a0al (2006) Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 44(4):1039\u20131046","journal-title":"Hepatology"},{"issue":"2","key":"1167_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2010.01.042","volume":"53","author":"T Lisman","year":"2010","unstructured":"Lisman\u00a0T et\u00a0al (2010) Hemostasis and thrombosis in patients with liver disease: the ups and downs. J\u00a0Hepatol 53(2):362\u2013371","journal-title":"J Hepatol"},{"key":"1167_CR23","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1038\/ctg.2015.27","volume":"6","author":"KK Sogaard","year":"2015","unstructured":"Sogaard\u00a0KK et\u00a0al (2015) Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism. Clin Transl Gastroenterol 6:e97","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"1167_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","volume":"51","author":"MA Zocco","year":"2009","unstructured":"Zocco\u00a0MA et\u00a0al (2009) Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J\u00a0Hepatol 51(4):682\u2013689","journal-title":"J Hepatol"},{"issue":"2","key":"1167_CR25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.27546","volume":"61","author":"F Nery","year":"2015","unstructured":"Nery\u00a0F et\u00a0al (2015) Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a\u00a0longitudinal study. Hepatology 61(2):660\u2013667","journal-title":"Hepatology"},{"issue":"4","key":"1167_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0168-8278(02)00208-8","volume":"37","author":"P Montalto","year":"2002","unstructured":"Montalto\u00a0P et\u00a0al (2002) Bacterial infection in cirrhosis impairs coagulation by a\u00a0heparin effect: a\u00a0prospective study. J\u00a0Hepatol 37(4):463\u2013470","journal-title":"J Hepatol"},{"issue":"4","key":"1167_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/hep.510290437","volume":"29","author":"GV Papatheodoridis","year":"1999","unstructured":"Papatheodoridis\u00a0GV et\u00a0al (1999) Infection and hemostasis in decompensated cirrhosis: a\u00a0prospective study using thrombelastography. Hepatology 29(4):1085\u20131090","journal-title":"Hepatology"},{"issue":"6","key":"1167_CR28","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s10620-023-07858-9","volume":"68","author":"AA Protopapas","year":"2023","unstructured":"Protopapas\u00a0AA et\u00a0al (2023) Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe? Dig Dis Sci 68(6):2237\u20132246","journal-title":"Dig Dis Sci"},{"issue":"10","key":"1167_CR29","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1111\/j.1572-0241.1999.01446.x","volume":"94","author":"Z Ben-Ari","year":"1999","unstructured":"Ben-Ari\u00a0Z et\u00a0al (1999) Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol 94(10):2977\u20132982","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1167_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cld.2008.09.008","volume":"13","author":"D Ferro","year":"2009","unstructured":"Ferro\u00a0D, Celestini\u00a0A, Violi\u00a0F (2009) Hyperfibrinolysis in liver disease. Clin Liver Dis 13(1):21\u201331","journal-title":"Clin Liver Dis"},{"issue":"10","key":"1167_CR31","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1111\/j.1572-0241.1999.02801.x","volume":"94","author":"JH Joist","year":"1999","unstructured":"Joist\u00a0JH (1999) AICF and DIC in liver cirrhosis: expressions of a\u00a0hypercoagulable state. Am J Gastroenterol 94(10):2801\u20132803","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1167_CR32","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1111\/j.1538-7836.2012.04901.x","volume":"10","author":"DC Rijken","year":"2012","unstructured":"Rijken\u00a0DC et\u00a0al (2012) Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests. J\u00a0Thromb Haemost 10(10):2116\u20132122","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1167_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/hep.1840170115","volume":"17","author":"F Violi","year":"1993","unstructured":"Violi\u00a0F et\u00a0al (1993) Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. Hepatology 17(1):78\u201383","journal-title":"Hepatology"},{"issue":"9","key":"1167_CR34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/s-0043-116856","volume":"55","author":"M G\u00f6tz","year":"2017","unstructured":"G\u00f6tz\u00a0M et\u00a0al (2017) S2k Guideline Gastrointestinal Bleeding \u2013 Guideline of the German Society of Gastroenterology DGVS. Z\u00a0Gastroenterol 55(9):883\u2013936","journal-title":"Z Gastroenterol"},{"key":"1167_CR35","unstructured":"Fuhrmann V, Braun G (2024) Treatment algorithm: Upper gastrointestinal bleeding. Med Klin Intensivmed Notfmed"},{"issue":"5","key":"1167_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/apt.17868","volume":"59","author":"M Vaishnav","year":"2024","unstructured":"Vaishnav\u00a0M et\u00a0al (2024) Comparison of 1\u2011day versus 3\u2011day intravenous terlipressin in cirrhosis patients with variceal bleeding: A\u00a0pilot randomised controlled trial. Aliment Pharmacol Ther 59(5):645\u2013655","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1167_CR37","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/hep.23893","volume":"52","author":"E Sola","year":"2010","unstructured":"Sola\u00a0E et\u00a0al (2010) Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology 52(5):1783\u20131790","journal-title":"Hepatology"},{"issue":"11","key":"1167_CR38","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","volume":"45","author":"JA Russell","year":"2019","unstructured":"Russell\u00a0JA (2019) Vasopressor therapy in critically ill patients with shock. Intensive Care Med 45(11):1503\u20131517","journal-title":"Intensive Care Med"},{"issue":"9","key":"1167_CR39","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa2008290","volume":"384","author":"F Wong","year":"2021","unstructured":"Wong\u00a0F et\u00a0al (2021) Terlipressin plus albumin for the treatment of type\u00a01 hepatorenal syndrome. N\u00a0Engl J Med 384(9):818\u2013828","journal-title":"N Engl J Med"},{"issue":"5","key":"1167_CR40","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","volume":"34","author":"NC Chavez-Tapia","year":"2011","unstructured":"Chavez-Tapia\u00a0NC et\u00a0al (2011) Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding \u2013 an updated Cochrane review. Aliment Pharmacol Ther 34(5):509\u2013518","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1167_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/00365520310000690","volume":"38","author":"K Soares-Weiser","year":"2003","unstructured":"Soares-Weiser\u00a0K et\u00a0al (2003) Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a\u00a0meta-analysis of randomized controlled trials. Scand J Gastroenterol 38(2):193\u2013200","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"1167_CR42","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","volume":"131","author":"J Fernandez","year":"2006","unstructured":"Fernandez\u00a0J et\u00a0al (2006) Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131(4):1049\u20131056 (quiz 1285)","journal-title":"Gastroenterology"},{"issue":"11","key":"1167_CR43","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1055\/a-1939-4887","volume":"54","author":"IM Gralnek","year":"2022","unstructured":"Gralnek\u00a0IM et\u00a0al (2022) Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 54(11):1094\u20131120","journal-title":"Endoscopy"},{"issue":"3","key":"1167_CR44","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","volume":"64","author":"MK Nadim","year":"2016","unstructured":"Nadim\u00a0MK et\u00a0al (2016) Management of the critically ill patient with cirrhosis: A\u00a0multidisciplinary perspective. J\u00a0Hepatol 64(3):717\u2013735","journal-title":"J Hepatol"},{"issue":"4","key":"1167_CR45","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000491106","volume":"34","author":"A Drolz","year":"2018","unstructured":"Drolz\u00a0A, Ferlitsch\u00a0A, Fuhrmann\u00a0V (2018) Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure. Visc Med 34(4):254\u2013258","journal-title":"Visc Med"},{"issue":"2","key":"1167_CR46","doi-asserted-by":"publisher","first-page":"192","DOI":"10.34067\/KID.0005342020","volume":"2","author":"B Szamosfalvi","year":"2021","unstructured":"Szamosfalvi\u00a0B et\u00a0al (2021) Regional Citrate Anticoagulation Protocol for Patients with Presumed Absent Citrate Metabolism. Kidney 2(2):192\u2013204","journal-title":"Kidney"},{"issue":"1","key":"1167_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1211801","volume":"368","author":"C Villanueva","year":"2013","unstructured":"Villanueva\u00a0C et\u00a0al (2013) Transfusion strategies for acute upper gastrointestinal bleeding. N\u00a0Engl J Med 368(1):11\u201321","journal-title":"N Engl J Med"},{"issue":"6","key":"1167_CR48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/a-0832-2694","volume":"57","author":"T Horvatits","year":"2019","unstructured":"Horvatits\u00a0T et\u00a0al (2019) Proton pump inhibitors in patients with liver cirrhosis \u2013 a\u00a0survey among hepatologists in Germany. Z\u00a0Gastroenterol 57(6):729\u2013733","journal-title":"Z Gastroenterol"},{"issue":"4","key":"1167_CR49","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/hep.28737","volume":"64","author":"G Dam","year":"2016","unstructured":"Dam\u00a0G et\u00a0al (2016) Proton pump inhibitors as a\u00a0risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology 64(4):1265\u20131272","journal-title":"Hepatology"},{"issue":"1","key":"1167_CR50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10620-023-08150-6","volume":"69","author":"ZY Wong","year":"2024","unstructured":"Wong\u00a0ZY et\u00a0al (2024) Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A\u00a0Meta-Analysis. Dig Dis Sci 69(1):289\u2013297","journal-title":"Dig Dis Sci"},{"issue":"11","key":"1167_CR51","doi-asserted-by":"publisher","first-page":"e110503","DOI":"10.1371\/journal.pone.0110503","volume":"9","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer\u00a0M et\u00a0al (2014) Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites. PLoS ONE 9(11):e110503","journal-title":"PLoS ONE"},{"issue":"1","key":"1167_CR52","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13063-022-06232-w","volume":"23","author":"MH Wehmeyer","year":"2022","unstructured":"Wehmeyer\u00a0MH et\u00a0al (2022) Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a\u00a0prospective, multicentre, controlled, randomized, double-blind trial. Trials 23(1):302","journal-title":"Trials"},{"issue":"5","key":"1167_CR53","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1055\/a-2112-1834","volume":"62","author":"V Fuhrmann","year":"2024","unstructured":"Fuhrmann\u00a0V et\u00a0al (2024) Einsatz von spezifischen Antidots bei DOAK-assoziierter schwerer gastrointestinaler Blutung \u2013 ein Expertenkonsensus \u2013 DOAK-Antagonisierung bei gastrointestinaler Blutung. Z\u00a0Gastroenterol 62(5):759\u2013768. https:\/\/doi.org\/10.1055\/a-2112-1834","journal-title":"Z Gastroenterol"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-024-01167-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01167-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T12:30:38Z","timestamp":1726662638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-024-01167-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1167"],"URL":"https:\/\/doi.org\/10.1007\/s00063-024-01167-3","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"type":"print","value":"2193-6218"},{"type":"electronic","value":"2193-6226"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Drolz gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}